You are here

Drug Safety Issues

Agency cites serious safety risk, lack of benefit
Agency cites deficiencies; Cantrell criticizes communication
Biogen, AbbVie blame reports of inflammatory brain disorders
Death toll linked with Asian plant rises to 44
Some liver-disease patients face risk of injury
Society for Healthcare Epidemiology of America provides guidance
Atcell is derived from adipose and meant for autologous use
FDA announces that four studies showed no increased risk of death
Setback follows announcement of adverse patient outcomes with dengue vaccine
Treatment targets advanced or metastatic HR-positive, HER2-negative cases
Patients with impaired liver function receiving too many doses
Products manufactured by PharmaTech were sold by three firms
Letter to health care providers warns of obesity treatment’s potential risks
Researchers suggest FDA regulation of yohimbe and energy products